Mumbai (Maharashtra) [India], December 28 (ANI): Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch of Molnupiravir in the country for COVID-19 treatment.
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
Washington [US], December 15 (ANI): US President Joe Biden on Tuesday (local time) said that Pfizer's COVID-19 antiviral pill mark a significant step forward in the path out of the pandemic.
New Delhi [India], December 9 (ANI): AstraZeneca's Evusheld (Tixagevimab co-packaged with Cilgavimab), a long-acting antibody (LAAB) combination, has received emergency use authorisation (EUA) in the US for the pre-exposure prophylaxis (prevention) of COVID-19, with first doses expected t
Washington [US], November 19 (ANI): The US Food and Drug Administration on Friday (local time) expanded the emergency use authorization (EUA) for the Pfizer and Moderna COVID-19 vaccine boosters signaling that the shots can be given to anyone aged 18+ at least six months after completion of
Washington [US], November 18 (ANI): Biden administration on Thursday (local time) announced that they have purchased 10 million treatment courses of Pfizer's antiviral COVID-19 pill.
New Delhi [India], November 6 (ANI): Bharat Biotech's US partner Ocugen has announced that it had asked the US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18.
Geneva [Switzerland], October 5 (ANI): World Health Organisation (WHO) has extended giving the emergency use authorization for Hyderabad-based Bharat Biotech's COVID-19 vaccine Covaxin to next week.
New Delhi [India], September 28 (ANI): The emergency use authorisation (EUA) for Bharat Biotech's COVID-19 vaccine Covaxin has once again been delayed by the World Health Organisation, said sources.
New Delhi [India], September 18 (ANI): World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to be delayed till October 5.
Hyderabad (Telangana) [India], September 6 (ANI): Hetero announced on Monday that the Drug Controller General of India (DCGI) has approved Emergency Use Authorization (EUA) for its generic version of Tocilizumab in India for the treatment of COVID-19 in hospitalised adults.
New Delhi [India], August 7 (ANI): US pharma giant Johnson and Johnson's single-dose COVID-19 vaccine Janssen has received approval for Emergency Use Authorization (EUA) in India, informed Union Health Minister Mansukh Mandaviya on Saturday.